Interaction between 5 genetic variants and allergy in glioma risk

American Journal of Epidemiology

Volumn 171, Issue 11, 2010, Pages 1165-1173

  Schoemaker, Minouk J ^a   Robertson, Lindsay ^a   Wigertz, Annette ^b   Jones, Michael E ^a   Hosking, Fay J ^a   Feychting, Maria ^b   Lönn, Stefan ^b   McKinney, Patricia A ^c   Hepworth, Sarah J ^c   Muir, Kenneth R ^d   Auvinen, Anssi ^e,f   Salminen, Tiina ^f   Kiuru, Anne ^e   Johansen, Christoffer ^g   Houlston, Richard S ^a   Swerdlow, Anthony J ^a  

^a INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^b KAROLINSKA INSTITUTE   (Sweden)

^c UNIVERSITY OF LEEDS   (United Kingdom)

^d UNIVERSITY OF WARWICK   (United Kingdom)

^e STUK RADIATION AND NUCLEAR SAFETY AUTHORITY   (Finland)

^f UNIVERSITY OF TAMPERE   (Finland)

^g INSTITUTE OF CANCER EPIDEMIOLOGY   (Denmark)

Author keywords

Allergy and immunology; Case control studies; Glioma; Polymorphism, single nucleotide

Indexed keywords

ALLELE; ASTHMA; CANCER; COHORT ANALYSIS; EPIDEMIOLOGY; ETIOLOGY; GENETIC VARIATION; GENOME; GENOTYPE-ENVIRONMENT INTERACTION; HEALTH RISK; IMMUNOASSAY; NUCLEIC ACID; POLYMORPHISM; SPATIOTEMPORAL ANALYSIS; TUMOR;

ADULT; AGED; ALLELE; ALLERGY; ARTICLE; ASTHMA; CANCER RISK; ECZEMA; FEMALE; GENETIC VARIABILITY; GENOME ANALYSIS; GENOTYPE; GLIOMA; HAY FEVER; HUMAN; MAJOR CLINICAL STUDY; MALE; SINGLE NUCLEOTIDE POLYMORPHISM;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ALLELES; ASTHMA; BRAIN NEOPLASMS; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; CONFIDENCE INTERVALS; ECZEMA; FEMALE; GENOME-WIDE ASSOCIATION STUDY; GENOTYPE; GLIOMA; GREAT BRITAIN; HUMANS; HYPERSENSITIVITY; LIKELIHOOD FUNCTIONS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; RHINITIS, ALLERGIC, SEASONAL; RISK FACTORS; SEX FACTORS; YOUNG ADULT;

DENMARK; FINLAND; SWEDEN; UNITED KINGDOM;

EID: 77952922118     PISSN: 00029262     EISSN: 14766256     Source Type: Journal    
DOI: 10.1093/aje/kwq075     Document Type: Article

References (31)

1. Central Brain Tumor Registry of the United States. Statistical Report: Primary Brain Tumors in the United States 1992-1997. Chicago, IL: Central Brain Tumor Registry of the United States; 2000.
2. Bondy ML, Scheurer ME, Malmer B, et al. Brain tumor epidemiology: consensus from the Brain Tumor Epidemiology Consortium. Cancer. 2008;113(7 suppl):1953-1968.
3. Hemminki K, Tretli S, Sundquist J, et al. Familial risks in nervous-system tumours: a histology-specific analysis from Sweden and Norway. Lancet Oncol. 2009;10(5):481-488.
4. Linos E, Raine T, Alonso A, et al. Atopy and risk of brain tumors: a meta-analysis. J Natl Cancer Inst. 2007;99(20): 1544-1550.
5. Burnet M. Cancer: a biological approach. III. Viruses associated with neoplastic conditions. IV. Practical applications. Br Med J. 1957;1(5023):841-847.
6. Dunn GP, Bruce AT, Ikeda H, et al. Cancer immunoediting: from immunosurveillance to tumor escape. Nat Immunol. 2002;3(11):991-998.
7. Schoemaker MJ, Swerdlow AJ, Hepworth SJ, et al. History of allergies and risk of glioma in adults. Int J Cancer. 2006; 119(9):2165-2172.
8. Wigertz A, Lönn S, Schwartzbaum J, et al. Allergic conditions and brain tumor risk. Am J Epidemiol. 2007;166(8): 941-950.
9. Shete S, Hosking FJ, Robertson LB, et al. Genome-wide association study identifies five susceptibility loci for glioma. Nat Genet. 2009;41(8):899-904.
10. Cardis E, Richardson L, Deltour I, et al. The INTERPHONE Study: design, epidemiological methods, and description of the study population. Eur J Epidemiol. 2007;22(9):647-664.
11. World Health Organization. International Classification of Diseases for Oncology. Third Edition. Geneva, Switzerland: World Health Organization; 2000.
12. World Health Organization. ICD-10: International Statistical Classification of Diseases and Related Health Problems. Tenth Revision. Geneva, Switzerland: World Health Organization; 1992.
13. Khoury MJ, Flanders WD. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: case-control studies with no controls! Am J Epidemiol. 1996; 144(3):207-213.
14. Stata Corporation. Stata Statistical Software: Release 10.0. College Station, TX: Stata Corporation; 2008.
15. Burton PR, Hansell AL, Fortier I, et al. Size matters: just how big is BIG? Quantifying realistic sample size requirements for human genome epidemiology. Int J Epidemiol. 2009;38(1): 263-273.
16. Brenner AV, Linet MS, Fine HA, et al. History of allergies and autoimmune diseases and risk of brain tumors in adults. Int J Cancer. 2002;99(2):252-259.
17. Wrensch M, Weinberg A, Wiencke J, et al. Does prior infection with varicella-zoster virus influence risk of adult glioma? Am J Epidemiol. 1997;145(7):594-597.
18. Wiemels JL, Wiencke JK, Patoka J, et al. Reduced immuno-globulin E and allergy among adults with glioma compared with controls. Cancer Res. 2004;64(22):8468-8473.
19. Wrensch M, Wiencke JK, Wiemels J, et al. Serum IgE, tumor epidermal growth factor receptor expression, and inherited polymorphisms associated with glioma survival. Cancer Res. 2006;66(8):4531-4541.
20. Schwartzbaum J, Jonsson F, Ahlbom A, et al. Cohort studies of association between self-reported allergic conditions, immune-related diagnoses and glioma and meningioma risk. Int J Cancer. 2003;106(3):423-428.
21. Dix AR, Brooks WH, Roszman TL, et al. Immune defects observed in patients with primary malignant brain tumors. J Neuroimmunol. 1999;100(1-2):216-232.
22. Walker PR, Calzascia T, Dietrich PY. All in the head: obstacles for immune rejection of brain tumours. Immunology. 2002; 107(1):28-38.
23. Harding NJ, Birch JM, Hepworth SJ, et al. Atopic dysfunction and risk of central nervous system tumours in children. Eur J Cancer. 2008;44(1):92-99.
24. Yin W, Rossin A, Clifford JL, et al. Co-resistance to retinoic acid and TRAIL by insertion mutagenesis into RAM. Onco-gene. 2006;25(26):3735-3744.
25. Das A, Banik NL, Ray SK. Differentiation decreased telo-merase activity in rat glioblastoma C6 cells and increased sensitivity to IFN-gamma and taxol for apoptosis. Neurochem Res. 2007;32(12):2167-2183.
26. Wager M, Menei P, Guilhot J, et al. Prognostic molecular markers with no impact on decision-making: the paradox of gliomas based on a prospective study. Br J Cancer. 2008;98(11): 1830-1838
27. Cancer Genome Atlas Research Network. Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature. 2008;455(7216):1061-1068.
28. Parsons DW, Jones S, Zhang X, et al. An integrated genomic analysis of human glioblastoma multiforme. Science. 2008; 321(5897):1807-1812.
29. Guo C, White PS, Weiss MJ, et al. Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas. Oncogene. 1999;18(35):4948-4957.
30. Vercelli D. Discovering susceptibility genes for asthma and allergy. Nat Rev Immunol. 2008;8(3):169-182.
31. McKusick-Nathans Institute of Genetic Medicine, Johns Hopkins University; National Center for Biotechnology Information, National Library of Medicine. Online Mendelian Inheritance in Man (OMIM) [database]. Bethesda, MD: National Library of Medicine; 2009. (http://www.ncbi.nlm.nih. gov/omim). (Accessed November 15,